Company Overview and News

2018-01-02 seekingalpha
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
Upvote
Downvote

2017-03-08 marketwired
VANCOUVER, BC--(Marketwired - March 08, 2017) - Kiska Metals Corporation (TSX VENTURE: KSK) ("Kiska") is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") involving Kiska and AuRico Metals Inc. (TSX: AMI) ("AuRico") and holders of common shares of Kiska ("Kiska Shares") ("Shareholders") and options of Kiska ("Kiska Options") ("Optionholders") (together, "Securityholders") pursuant to which AuRico acquired all of the issued and outstanding Kiska Shares that were not already owned by AuRico or its affiliates.
Upvote
Downvote

2017-03-03 marketwired
VANCOUVER, BC--(Marketwired - March 03, 2017) - Kiska Metals Corporation (TSX VENTURE: KSK) ("Kiska") is pleased to announce that it has received a final order from the Supreme Court of British Columbia dated March 3, 2017 approving the previously announced plan of arrangement (the "Arrangement") involving Kiska and AuRico Metals Inc. (TSX: AMI) ("AuRico") and holders of common shares of Kiska ("Kiska Shares") ("Shareholders") and options of Kiska ("Kiska Options") ("Optionholders") (together, "Securityholders") pursuant to which AuRico will acquire all of the issued and outstanding Kiska Shares that are not already owned by AuRico or its affiliates.
Upvote
Downvote

2017-02-16 seekingalpha
If you are looking for a three-bagger, you can't go wrong with VanEck Vectors Junior Gold Miners ETF (NYSEARCA:GDXJ). And if you are looking for a five-bagger, PureFunds ISE Junior Silver ETF (NYSEARCA:SILJ) will do the trick. However, if you want a good risk/reward stock with 5+ bagger potential, those are becoming harder to find. From the recent selloff in gold/silver miners, I have one for you.
Upvote
Downvote

2017-02-10 marketwired
VANCOUVER, BC--(Marketwired - February 09, 2017) - Kiska Metals Corporation (TSX VENTURE: KSK) ("Kiska" or the "Company") is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm which provides voting recommendations to institutional investors, has recommended that securityholders of Kiska vote FOR the resolution to approve the acquisition of Kiska by AuRico Metals Inc.
Upvote
Downvote

2017-02-01 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 1, 2017) - Kiska Metals Corporation (TSX VENTURE:KSK) ("Kiska") is pleased to announce that it has filed and mailed its management information circular (the "Circular") and related proxy materials (the "Meeting Materials") to its holders of common shares ("Kiska Shares") ("Shareholders") and options ("Kiska Options") ("Optionholders") (together, "Securityholders") in connection with the special meeting of Securityholders to be held at 10:00 a.
Upvote
Downvote

2017-01-06 marketwired
VANCOUVER, BC--(Marketwired - January 06, 2017) - Kiska Metals Corporation (TSX VENTURE: KSK) ("Kiska") is pleased to announce the closing of its previously announced non-brokered private placement offering (the "Offering") to AuRico Metals Inc. ("AuRico"). Under the Offering, AuRico subscribed for 12,900,000 common shares in the capital of Kiska (the "Offered Shares") representing approximately 9.
Upvote
Downvote

2017-01-01 seekingalpha
Last January I posted an article of the 20 best risk/reward high return gold & silver mining stocks. Someone asked me to do it again for 2017. There are six holdovers from last year, and 14 new stocks. This list includes the top 20 stocks with the best risk/reward characteristics to become 5+ baggers in the long term at higher gold and silver prices. Most of these stocks are dependent on higher gold/silver prices, giving them a higher degree of risk than a low cost producer.
Upvote
Downvote

2016-12-30 prnewswire
VANCOUVER, Dec. 30, 2016 /PRNewswire/ - Garibaldi Resources Corp. (TSX; GGI) (the ''Company" or "Garibaldi") is pleased to provide an update on several of its British Columbia properties as it follows a strategic path to make 2017 a breakthrough "Discovery Year" for the Company in both B.C. and Mexico.
Upvote
Downvote

2016-12-24 prnewswire
TORONTO, 24 de diciembre de 2016 /PRNewswire/ -- AuRico Metals Inc. (TSX: AMI) ("AuRico") y Kiska Metals Corporation (TSX.V: KSK) ("Kiska") se complacen al anunciar que han llegado a un acuerdo definitivo (el "Acuerdo") tras el cual AuRico va a adquirir todos los valores emitidos y destacados de Kiska en forma de un plan estatutario de acuerdo a través de la Business Corporations Act (British Columbia) (el "Acuerdo").
Upvote
Downvote

2016-12-23 reuters
Dec 23 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote
Downvote

2016-12-23 feeds.reuters
* Tesla CEO Musk tweet - "Looks like we might be ready to rollout most of Autopilot functionality for HW2 towards the end of next week"
Upvote
Downvote

2016-12-23 feeds.reuters
* Kiska Metals Corp - under terms, holders of Kiska shares to receive about 0.0667 of Aurico common share plus c$0.016 in cash for each Kiska share held
Upvote
Downvote

2016-12-23 feeds.reuters
* BFK will acquire all of securities of THC by way of a three-cornered amalgamation Source text for Eikon: Further company coverage:
Upvote
Downvote

2016-12-23 feeds.reuters
* Mosaic Capital - common share purchase warrants entitling Fairfax to acquire up to 17 million common shares of mosaic at $8.81 per share for 7 years Source text for Eikon: Further company coverage:
Upvote
Downvote
Related Articles
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET